Evidence map›Paper›PMID 27574782›Full record

ArticleMolecular therapy. Nucleic acids2016

Electrotransfer parameters as a tool for controlled and targeted gene expression in skin.

Spela Kos, Tanja Blagus, Maja Cemazar, Ursa Lampreht Tratar, Monika Stimac, Lara Prosen, Tanja Dolinsek, Urska Kamensek, Simona Kranjc, Lars Steinstraesser and 3 more

Open access · goldAbstract read
In one paragraph

Article in Molecular therapy. Nucleic acids, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Transdermal delivery for gene therapy.Drug delivery and translational research · 2022
    Review
  6. Article
  7. In vitro and in vivo correlation of skin and cellular responses to nucleic acid delivery.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2022
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Spela KosDepartment of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
Tanja BlagusDepartment of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
Maja CemazarDepartment of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
Ursa Lampreht TratarDepartment of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
Monika StimacDepartment of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
Lara ProsenDepartment of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
Tanja DolinsekDepartment of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
Urska KamensekDepartment of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
Simona KranjcDepartment of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
Lars SteinstraesserDepartment of Plastic Surgery, Burn Center, BG University Hospital Bergmannsheil, Ruhr University Bochum, Bochum, Germany.
Gaëlle VandermeulenUniversité Catholique de Louvain, Louvain Drug Research Institute, Advanced Drug Delivery and Biomaterials, Brussels, Belgium.
Véronique PréatUniversité Catholique de Louvain, Louvain Drug Research Institute, Advanced Drug Delivery and Biomaterials, Brussels, Belgium.
Gregor SersaDepartment of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
Institute of Oncology Ljubljana · SIUCLouvain · BERuhr University Bochum · DEUniversity of Primorska · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skin is an attractive target for gene electrotransfer. It consists of different cell types that can be transfected, leading to various responses to gene electrotransfer. We demonstrate that these responses could be controlled by selecting the appropriate electrotransfer parameters. Specifically, the application of low or high electric pulses, applied by multi-electrode array, provided the possibility to control the depth of the transfection in the skin, the duration and the level of gene expression, as well as the local or systemic distribution of the transgene. The influence of electric pulse type was first studied using a plasmid encoding a reporter gene (DsRed). Then, plasmids encoding therapeutic genes (IL-12, shRNA against endoglin, shRNA against melanoma cell adhesion molecule) were used, and their effects on wound healing and cutaneous B16F10 melanoma tumors were investigated. The high-voltage pulses resulted in gene expression that was restricted to superficial skin layers and induced a local response. In contrast, the low-voltage electric pulses promoted transfection into the deeper skin layers, resulting in prolonged gene expression and higher transgene production, possibly with systemic distribution. Therefore, in the translation into the clinics, it will be of the utmost importance to adjust the electrotransfer parameters for different therapeutic approaches and specific mode of action of the therapeutic gene.

Identifiers

PMID27574782
PMCPMC5023408
OpenAlexW2517866781

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.